Study Reveals Increasing Delays in Cancer Treatment Initiation

By Simone Carter

Delays in the initiation of cancer treatment have been increasing across six major types of cancer in the United States, according to a study published in JAMA Surgery and summarized by The Eastleigh Voice. The study analyzed data from the U.S. National Cancer Database, covering the period from January 2012 to December 2023.

The research focused on patients with stage I–III cancers eligible for surgery, including breast, colon, lung, pancreatic, oesophageal, and gastric cancers. It found that median waiting times from diagnosis to treatment have increased for all six cancer types. For instance, breast cancer patients saw delays rise from 34 days in 2012 to 45 days in 2023, while lung cancer patients experienced an increase from 41 to 53 days.

The study also highlighted disparities in treatment delays, noting that Black patients, those from lower socioeconomic backgrounds, and Medicaid recipients faced longer waits. Additionally, patients treated at large academic medical centers experienced more significant delays compared to those at smaller community hospitals.

Researchers attributed these rising delays to systemic and administrative issues, such as institutional transfers, logistical hurdles in record sharing, and complex referral pathways. The study called for system-level interventions to address these issues, particularly to reduce care inequalities for vulnerable populations.